ENDPOINTS

Eli Lilly teams up with RNA editing biotech for hearing loss

Eli Lilly is building out its gene therapy pipeline for hearing loss through a new deal with RNA-focused startup Rznomics. The Indianapolis drug giant and Seongnam-based biotech will work together on sensorineural hearing loss in ...

May 15, 2025 - 18:34
 0
Eli Lilly teams up with RNA editing biotech for hearing loss
Eli Lilly is building out its gene therapy pipeline for hearing loss through a new deal with RNA-focused startup Rznomics. The Indianapolis drug giant and Seongnam-based biotech will work together on sensorineural hearing loss in ...
Read More

Tags:

Previous Article

World’s first personalized CRISPR therapy given to baby with genetic disease

Next Article

SpotitEarly launches in U.S. with $20.3M to detect cancer using AI and dogs

Related Posts

AI biotech Insilico Medicine goes for third attempt at Hong Kong IPO

AI biotech Insilico Medicine goes for third attempt at ...

May 9, 2025  0

Cytokinetics gets an 'incremental' win for delayed heart drug

Cytokinetics gets an 'incremental' win for delayed hear...

May 13, 2025  0

Controversial doctor Vinay Prasad named CBER director

Controversial doctor Vinay Prasad named CBER director

May 6, 2025  0